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INTRODUCTION  
In the recent decades, controlled release dosage forms 
have made significant progress in terms of formulation 
technology and therapeutic efficacy. Drug release from 
the formulation should be at a Predictable rate for better 
patient compliance. Polymers, which are used as release 
retarding materials in the design of controlled release 
dosage forms, play an important role in controlling the 
release of drug from these dosage forms. Though a wide 
range of polymers and other release retarding polymeric 
materials are available, there is a  need to develop new 
materials as the newly discovered API’s as well as 
current Drugs are posing a great deal of challenge in 
formulating safe and effective formulations. Xanthan 
Gum is a natural, biodegradable polymer and modified 
Xanthan Gum is reported as fillers
1
, Disintegrants and 
dry binders. In the present study, a new Xanthan Gum 
based polymer, Deacetylated Xanthan Gum was 
synthesized and evaluated for its application in 
controlled release
2, 3
. Among the various approaches, 
preparation of matrix tablet is one of the Easiest 
approaches for obtaining a controlled release. 
Simvastatin containing matrix tablets were prepared 
employing Deacetylated Xanthan Gum and evaluated 
for controlled release. Controlled release formulation is 
needed for simvastatin because of it is a BCS Class II 
Drug with low dissolution and high permeability
4
. 
MATERIALS AND METHODS  
Materials  
Simvastatin is a gift sample from M/s. Dr. Reddy’s 
Labs Pvt. Ltd., Hyderabad. All other materials used 
were of Pharmacopoeial grade.  
Methods  
Preparation of deacetylated xanthan gum 
The reactions for deacetylation of xanthan Gum was 
carried out with 1% xanthan solutions and sodium 
hydroxide, in the concentrations 0.01 mol.L
–1
. An 
Erlenmeyer flask (240 ml) containing 125 ml of the 
above solution is incubated in an orbital shaker at 300 
RPM. The reaction was pre-set a time of 3 hours and a 
temperature of 25 °C. The solutions were neutralized 
with hydrochloric acid (2mol.l
–1
). The biopolymer was 
recovered by precipitation with ethanol, dried in an 
oven at 56 °C, until reaching a constant weight and then 
milled with a disc mill to a particle size of 0.5 mm.  
Preparation of tablets  
Matrix tablets each containing 40 mg of Simvastatin 
were prepared employing Deacetylated Xanthan Gum 
in different proportions of drug and polymer. The 
required quantities of Simvastatin and matrix materials 
were mixed thoroughly in a mortar by following 
geometric dilution technique. The binder solution (5% 
starch) was added and mixed thoroughly to form wet 
mass. The mass was passed through mesh No. 12 to 
obtain wet granules. The wet granules were dried at 56° 
for 4 h. The dried granules were passed through mesh 
No. 16 to break the aggregates. The lubricants talc 
(5mg) and magnesium stearate (5mg) were passed 
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through mesh No. 100 onto dry granules and blended in 
a closed polyethylene bag. The tablet granules were 
compressed into tablets on a rotary multi-station tablet 
punching machine (Simach Machinery Co. Pvt. Ltd., 
Mumbai) with a hardness of 6 - 8kg/sq.cm. Using 9 mm 
round and Concave punches. Hardness of tablets was 
tested using a Monsanto hardness tester. Friability of 
tablets was determined in a Roche Friabilator.  
 
Table 1: Composition of Deacetylated Xanthan Gum based controlled release tablets of Simvastatin 
Formulation code F1 F2 F3 F4 F5 F6 F7 F8 F9 
Simvastatin 40 40 40 40 40 40 40 40 40 
Deacetylated Xanthan gum 130 120 110 100 80 60 40 20 00 
Lactose 70 75 75 80 85 90 95 100 105 
Starch 20 25 25 30 35 40 45 40 55 
MCC 40 40 45 45 40 55 60 65 70 
PVP-K30 40 40 45 45 40 55 60 65 70 
Magnesium stearate 5 5 5 5 5 5 5 5 5 
Talc 5 5 5 5 5 5 5 5 5 
 
In vitro dissolution studies 
Simvastatin content of the tablets was estimated by UV- 
Visible spectrophotometric method based on the 
measurement of absorbance at 238 nm in phosphate 
buffer of pH 7.4. The method obeyed Beer’s law in the 
concentration range 0-10 µg/ml. No interference from 
the excipients used was observed. Drug release from 
matrix tablets was studied using 8 station dissolution 
rate test apparatus (Lab India, Disso 2000) employing a 
paddle stirrer at 40 RPM and at 37±1°C. Phosphate 
buffer of pH 7.4 (900 ml) was used as dissolution fluid. 
Samples of 5 ml of each were withdrawn at different 
time intervals over a period of 12 h. Each sample 
withdrawn was replaced with an equal amount of fresh 
dissolution medium. Samples were suitably diluted and 
assayed at 238 nm for Simvastatin using a Shimadzu 
UV-140 double beam UV-spectrophotometer. The drug 
release experiments were conducted in triplicate. 
Results of in-vitro dissolution studies obtained were 
tabulated and shown graphically according to following 
models of data treatment
5
.  
1. Cumulative Percentage Drug Release V/s Time in 
Hours.  
2. Cumulative Percentage Drug Retained V/s Time in 
Hours.  
3. Higuchi’s Classical Diffusion Equation - Cumulative 
Percentage Drug Release V/s Square Root T.  
4. Korsymeyer Peppas Equation – log cumulative % 
Drug release V/s log Time 
7 
 
RESULTS AND DISCUSSION 
 
Figure 1: % Cumulative drug release graph for suitable formulation 
 
Deacetylated Xanthan Gum was prepared by 
gelatinizing Xanthan Gum in the presence of sodium 
hydroxide. The Deacetylated Xanthan Gum polymer 
formed was found to be dry and free flowing powder. It 
was insoluble in water, aqueous fluids of acidic and 
alkaline pH. When tested for melting point, the polymer 
charred at 2200 C. Matrix tablets each containing 40 mg 
of Simvastatin could be prepared employing different 
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proportions of Deacetylated Xanthan Gum polymer by 
wet granulation technique. Hardness of the tablets was 
found to be in the range of 6 – 8 kg/ sq. cm. Weight loss 
in the friability test was less than 1% in all the batches. 
All the tablets contained Simvastatin within 100 ± 5% 
of the labeled amount. Tablets have not disintegrated in 
water and aqueous, acidic (pH 1.2) and alkaline (pH 
7.4) fluids. As such, the prepared tablets were of good 
quality with regard to drug content, hardness and 
friability. As the tablets formulated employing 
Deacetylated Xanthan Gum were non-disintegrating in 
acidic and alkaline fluids, they are considered suitable 
for oral controlled release. Release parameters of the 
tablets are summarized in Table 2. Simvastatin release 
from the prepared tablets was slow and spread over 12 
h. and depended on the concentration of Deacetylated 
Xanthan Gum polymer. When the release data were 
analyzed as per zero and first order kinetic models, the 
best fit with higher correlation (r
2
 > 0.9581) was 
observed with zero order models indicating that the 
drug release from all the tablets followed zero order 
kinetics. When the release data were analyzed  for 
Peppas equation, the release exponent ‘n’ was found in 
the range 0.497 – 0.886 indicating non – Fickian 
(anomalous) diffusion as the release mechanism from 
all the tablets prepared. Plots of percent released versus 
square root of time was found to be linear (r > 0.948) 
with most of the batches of tablets prepared indicating 
that the drug release from the tablets was diffusion 
controlled. As the polymer concentration was increased, 
release rate was decreased. The Good linear relationship 
was observed between percent polymer and release rate. 
Thus the drug release from the matrix tablets could be 
controlled by varying the proportion of drug: polymer 
in the matrix. Hence, matrix tablets formulated 
employing Deacetylated Xanthan Gum (F1) is 
considered suitable for controlling release of 
Simvastatin over 12 h. 
 
 
Figure 2: Zero Order release graph for suitable formulation 
 
 
Figure 4: Higuchi’s release profile for suitable formulation 
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Figure 5:  Korsymeyer Peppas release profile for suitable formulation 
 
 
Figure 6:  First order release profile for suitable formulation 
CONCLUSIONS  
Matrix tablets formulated employing Deacetylated 
Xanthan Gum, a new Xanthan Gum based polymer, are 
suitable for oral controlled release of Simvastatin. Drug 
release from the tablets formulated employing 
Deacetylated Xanthan Gum was slow and spread over 
12 h. and depended on percent polymer in the tablet. 
Release was diffusion controlled and followed zero 
order kinetics. Non – Fickian diffusion was the drug 
release mechanism from the formulated tablets. 
Simvastatin release from matrix tablets F1 formulated 
employing 37 % Deacetylated Xanthan Gum polymer is 
Suitable controlled release formulation. Deacetylated 
Xanthan Gum polymer is suitable for the design of oral 
controlled release tablets. 
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